In terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015 as amended, Biofil Chemicals & Pharmaceuticals has informed that its Registrar and Share Transfer Agent i.e., Ankit Consultancy has duly completed the process of sending intimation via email on 10th February, 2023 to the Members of the Biofil Chemicals And Pharmaceuticals pertaining to SEBI Circular No. SEBI/HO/OIAE/2023/03391dated January 27, 2023 read together with SEBI /HO/ MIRSD/MIRSD_RTAMB/P/CIR/2022/76 dated May 30, 2022 regarding availability of Dispute Resolution Mechanism at Stock Exchanges against Company/Registrar to an Issue and Share Transfer Agents (RTA). Summary of the aforesaid communications is being made available on website at: www.biofilgroup.net under Investors Section.
The above information is a part of company’s filings submitted to BSE.